Population-specific limited sampling strategies for therapeutic drug monitoring of mycophenolic acid

Journal of Postgraduate Medicine

Volumn 52, Issue 4, 2006, Pages 244-

  Van Hest, Reinier M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

AREA UNDER THE CURVE; DRUG BLOOD LEVEL; DRUG MONITORING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; LOW DRUG DOSE; NOTE; POPULATION RESEARCH; RACE DIFFERENCE; SAMPLING;

AREA UNDER CURVE; DRUG MONITORING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MYCOPHENOLIC ACID;

EID: 33845241480     PISSN: 00223859     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (5)

1. Van Gelder T, Meur YL, Shaw LM, Oellerich M, Denofrio D, Holt C, et al. Therapeutic drug monitoring of mycophenolate mofetil in transplantation. Ther Drug Monit 2006;28:145-54.
2. Fleming DH, Mathew BS, John GT, Chandy SJ, Manivannan J, Jeyaseelan V. A six hour extrapolated sampling strategy for monitoring mycophenolic acid in renal transplant patients in the Indian subcontinent. J Postgrad Med 2006;52:248-52.
3. Hesselink DA, Van Hest RM, Mathot RA, Bonthuis F, Weimar W, de Bruin RW, et al. Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2. Am J Transplant 2005;5:987-94.
4. Shaw LM, Korecka M, Venkataramanan R, Goldberg L, Bloom R, Brayman KL. Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies. Am J Transplant 2003;3:534-42.
5. David OJ, Johnston A. Limited sampling strategies for estimating cyclosporin area under the concentration-time curve: Review of current algorithms. Ther Drug Monit 2001;23:100-14.